Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronghui Xie

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Virology Journal|February 1, 2025
Development of a duplex real-time recombinase aided amplification assay for the simultaneous and rapid detection of PCV3 and PCV4Renjie Sun, Hanze Liu, Siqi Sun, et al.
Expert Review of Clinical Pharmacology|May 16, 2019
Effect of rilpivirine on the pharmacokinetics of methadone in HIV-Infected Chinese patientsSuyun Lei, Lizhu Hong, Cuixian Yang, et al.
Current HIV Research|April 27, 2021
Outcomes of Methadone Maintenance Therapy Combined with Rilpivirine/Efavirenz in Treatment-Naive HIV-Infected PatientsShizhen Huang, Cuixian Yang, Jiaying Xin, et al.
Vaccine|June 8, 2011
Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbitsHanping Zhu, Xiaohang Ding, Xuekui Chen, et al.
Hepatology International|September 12, 2018
Tolerable and curable treatment in HIV/HCV co-infected patients using anti-HCV direct antiviral agents: a real-world observation in ChinaYuanyuan Li, Linghua Li, Jun Liu, et al.
Emerging Microbes & Infections|April 9, 2020
Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trialJun Chen, Rong Chen, Yinzhong Shen, et al.
The Lancet Regional Health. Western Pacific|August 15, 2022
The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysisXinsheng Wu, Guohui Wu, Yanmin Ma, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Virology Journal|February 1, 2025
Development of a duplex real-time recombinase aided amplification assay for the simultaneous and rapid detection of PCV3 and PCV4Renjie Sun, Hanze Liu, Siqi Sun, et al.
Expert Review of Clinical Pharmacology|May 16, 2019
Effect of rilpivirine on the pharmacokinetics of methadone in HIV-Infected Chinese patientsSuyun Lei, Lizhu Hong, Cuixian Yang, et al.
Current HIV Research|April 27, 2021
Outcomes of Methadone Maintenance Therapy Combined with Rilpivirine/Efavirenz in Treatment-Naive HIV-Infected PatientsShizhen Huang, Cuixian Yang, Jiaying Xin, et al.
Vaccine|June 8, 2011
Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbitsHanping Zhu, Xiaohang Ding, Xuekui Chen, et al.
Hepatology International|September 12, 2018
Tolerable and curable treatment in HIV/HCV co-infected patients using anti-HCV direct antiviral agents: a real-world observation in ChinaYuanyuan Li, Linghua Li, Jun Liu, et al.
Emerging Microbes & Infections|April 9, 2020
Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trialJun Chen, Rong Chen, Yinzhong Shen, et al.
The Lancet Regional Health. Western Pacific|August 15, 2022
The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysisXinsheng Wu, Guohui Wu, Yanmin Ma, et al.
Pageof 2